𝐀𝐬𝐬𝐞𝐬𝐬𝐢𝐧𝐠 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬: 𝐌𝐎𝐇/𝐑𝐨𝐜𝐡𝐞 𝐌𝐎𝐔'𝐬 𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐚𝐫𝐞 𝐀𝐜𝐜𝐞𝐬𝐬
Nairobi, Kenya- 22nd September 2023 -Harry Kimtai, on Friday played host to the MOH/Roche MOU implementation committee.
The committee convened to evaluate the milestones accomplished during the inaugural year of MOU implementation.
Notably, the Herceptin Access Program has made significant strides, facilitating broader access for breast cancer patients to this targeted drug, which is now fully covered under NHIF. This initiative aims to mitigate the financial burden of cancer-related expenditures.